APOE, Sex, and Alzheimer’s Disease: Investigating Their Interplay in the Egyptian Population
Mohamad Rosni Othman(National Defence University of Malaysia), Mohamed Salama(Mansoura University), Amna Ibrahim(Beni-Suef University), Gharib Fawi(Sohag University), Sara Elfarrash(Mansoura University), Samer Salama(Mansoura University), Nesma G. Elsheikh(Ain Shams University), Nourelhoda A. Haridy(Assiut University), Noha Abo Elftoh(Assiut University), Samir Shamma(American University in Cairo), Eman Ali(Beni-Suef University), Mie Rizig(National Hospital for Neurology and Neurosurgery), Mohamed H. Yousef(American University in Cairo), Noha A. Yousri(Hamad bin Khalifa University), Heba M. Tawfik(Ain Shams University), Gellan K. Ahmed(Assiut University), Agsha Atputhavadivel(National Hospital for Neurology and Neurosurgery), Ahmed Qayaty(Beni-Suef University), Shimaa Adel Heikal(American University in Cairo), Muhammad Abdelshafi(Mansoura University Hospital), Eman M. Khedr(Assiut University Hospitals)
Cited by 0
Related Papers
FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline <i>BRCA</i>-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy
|Clinical Cancer Research|2015|532
FDA Approval: Palbociclib for the Treatment of Postmenopausal Patients with Estrogen Receptor–Positive, HER2-Negative Metastatic Breast Cancer
|Clinical Cancer Research|2015|377
FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer
|Clinical Cancer Research|2014|350
Analysis of the Association Between Adverse Events and Outcome in Patients Receiving a Programmed Death Protein 1 or Programmed Death Ligand 1 Antibody
|Journal of Clinical Oncology|2019|348